Rhabdomyolysis due to rosuvastatin in a patient with ROHHAD syndrome
- PMID: 34600840
- DOI: 10.1016/j.jacl.2021.09.002
Rhabdomyolysis due to rosuvastatin in a patient with ROHHAD syndrome
Abstract
We report a 13-year-old female with rapid-onset obesity, hypothalamic dysfunction, hypoventilation, and autonomic dysregulation (ROHHAD) syndrome, panhypopituitarism, dyslipidemia, type 2 diabetes mellitus, and nonalcoholic fatty liver disease, who developed rhabdomyolysis and acute kidney injury, two weeks after switching from lovastatin to rosuvastatin. She had been on lovastatin for eight years without any adverse effects.
Keywords: Pediatric obesity; ROHHAD syndrome; Rhabdomyolysis; Rosuvastatin; Secondary dyslipidemia.
Copyright © 2021 National Lipid Association. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest All the authors have no con-flicts of interest to disclose.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources